AgingResearch.NewsJoin free

TTCM2-MS

Intervention

1 paper studies it2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • 2 of 2 findings with company ties
  • Animals1

Outcomes

2

Cognitive function

upin mice1

1 study

  1. TTCM2-MS improves cognitive function in mice.

    “elevated synaptic proteins, and improved cognitive functions in aged tauopathy mice”

    Animalstauopathymicellessingle intranasal dose

    Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice

    Science translational medicineJul 3, 2024

Pathological tau

downin mice1

1 study

  1. TTCM2-MS decreases pathological tau in mice.

    “a single intranasal dose of TTCM2-ms effectively cleared pathological tau”

    Animalstauopathymicellessingle intranasal dose

    Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice

    Science translational medicineJul 3, 2024

More on Pathological tau

Latest

Related